Literature DB >> 7192205

Intermediate-acting insulin preparations: NPH and lente.

T Deckert.   

Abstract

Physicochemically, NPH and lente insulins differ in size of crystals, content of protamine and zinc, and often in species composition, since lente always contains beef insulin. The duration of the hypoglycemic effect of lente insulin seems to be longer than 24 h, whereas that of NPH insulin does not exceed 24 h when given in amounts of 0.2-0.3 U/kg body wt. Moreover, NPH and lente insulins differ in their ability to form stable mixtures with neutral insulin solutions, since only NPH insulin can be mixed with regular insulin without changing the specific course of effect of regular insulin. Highly purified porcine NPH and the lente-like porcine insulin preparation. Monotard, do not seem to differ regarding side effects (lipoatrophy, immunogenicity). However, highly purified lente insulin (containing beef insulin) seems to be more immunogenic than highly purified porcine NPH insulin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7192205     DOI: 10.2337/diacare.3.5.623

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

1.  Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Perriello; E Torlone; S Di Santo; C Fanelli; P De Feo; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

2.  Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.

Authors:  M Lunetta; M di Mauro; S Crimi; L Sudano; L Mughini
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

3.  Reversible adsorption of soluble hexameric insulin onto the surface of insulin crystals cocrystallized with protamine: an electrostatic interaction.

Authors:  S W Dodd; H A Havel; P M Kovach; C Lakshminarayan; M P Redmon; C M Sargeant; G R Sullivan; J M Beals
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

4.  Modulating Insulin Fibrillation Using Engineered B-Chains with Mutated C-Termini.

Authors:  Mohsen Akbarian; Reza Yousefi; Ali Akbar Moosavi-Movahedi; Atta Ahmad; Vladimir N Uversky
Journal:  Biophys J       Date:  2019-09-23       Impact factor: 4.033

5.  An acute need for awareness of insulin injection guidelines in operative and intensive care units.

Authors:  Sukhminder Jit Singh Bajwa; Sanjay Kalra; Manash P Baruah; Sukhwinder Kaur Bajwa
Journal:  Anesth Essays Res       Date:  2013 Jan-Apr

6.  Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.

Authors:  U Fischer; E J Freyse; E Jutzi; W Besch; M Raschke; S Höfer; G Albrecht
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

7.  Treatment of diabetes with insulin. From art to science.

Authors:  M C Riddle
Journal:  West J Med       Date:  1983-06

Review 8.  Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015.

Authors:  Nikhil Tandon; Sanjay Kalra; Yatan Pal Singh Balhara; Manash P Baruah; Manoj Chadha; Hemraj B Chandalia; Subhankar Chowdhury; Kesavadev Jothydev; Prasanna K M Kumar; Madhu S V; Ambrish Mithal; Sonal Modi; Shailesh Pitale; Rakesh Sahay; Rishi Shukla; Annamalai Sundaram; Ambika G Unnikrishnan; Subhash K Wangnoo
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

Review 9.  Insulin glargine 300 U/mL in the management of diabetes: clinical utility and patient perspectives.

Authors:  Bastiaan E de Galan
Journal:  Patient Prefer Adherence       Date:  2016-10-17       Impact factor: 2.711

10.  Forum for injection techniques, India: the first Indian recommendations for best practice in insulin injection technique.

Authors:  Sanjay Kalra; Yatan Pal Singh Balhara; Manash P Baruah; Manoj Chadha; Hemraj B Chandalia; Subhankar Chowdhury; K M Prasanna Kumar; Sonal Modi; Shailesh Pitale; Rishi Shukla; Rakesh Sahay; Annamalai Sundaram; Ambika G Unnikrishnan; Subhash K Wangnoo
Journal:  Indian J Endocrinol Metab       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.